Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Alkem Laboratories Limited Call Transcript 2024

Nov 6, 2024

61611_rns_2024-11-06_bec0e18b-6e14-4b32-9ff2-fa345cae73fb.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [595 x 128] intentionally omitted <==

06[th] November, 2024

To,

The Corporate Relationship Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Bandra East, Mumbai 400 001. Mumbai 400 051. Scrip Code: 539523 Scrip Symbol: ALKEM

Sub: Intimation of Conference Call on Q2FY25

Dear Sir(s) / Madam,

With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q2 and H1FY25 financial results will be held on Wednesday, 13[th] November, 2024 at 04.00 p.m.

Please find attached herewith the conference call details.

Kindly take note of the same.

Sincerely, For Alkem Laboratories Limited MANISH Digitally signed by MANISH NARANG NARANG Date: 2024.11.06 12:57:23 +05'30' Manish Narang President – Legal, Company Secretary & Compliance Officer

==> picture [595 x 130] intentionally omitted <==

Invite for Q2 & H1FY25 Conference Call at 4 pm IST, November 13, 2024

Mumbai, November 06, 2024: Alkem Laboratories Ltd. (NSE: ALKEM, BSE: 539523, Bloomberg: ALKEM.IN, Reuters: ALKE.NS) will hold a conference call for investors and analysts on Wednesday, November 13, 2024, from 4:00 pm to 5:00 pm IST to discuss its Q2 and H1FY25 financial results. The call will follow the announcement of the Company’s Q2 and H1FY25 financial results on Wednesday, November 13, 2024.

Alkem Laboratories Ltd. will be represented on the call by:

Dr. Vikas Gupta – CEO Mr. Nitin Agrawal – CFO

Motilal Oswal Securities Ltd. will host the call.

Details of the conference call are as follows:

Time: 4:00 pm IST (GMT + 5:30) on Wednesday, November 13, 2024

Dial in Details:

India: +91 22 6280 1149 / +91 22 7115 8050

International Toll-Free

USA : 1 866 746 2133 UK : 0 808 101 1573 Singapore : 800 101 2045 Hong Kong : 800 964 448

Express Join with Diamond Pass

https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=6553086& linkSecurityString=2c22b92002

You are requested to dial in 10 mins ahead of the scheduled start time.

Purvi Shah Tushar Manudhane Head of Investor Relations Motilal Oswal Securities Ltd. Alkem Laboratories Ltd. Tel.: +91 22 6129 1536 / +91 82911 38039 Mobile: +91 84337 00890 E-mail: [email protected] Tel.: +91 22 3982 9999 Ext: 9447 E-mail: [email protected]